Literature DB >> 23826747

The spectrum of β-thalassemia mutations in Baghdad, Central Iraq.

Nasir A S Al-Allawi1, Bassam M S Al-Mousawi, Ameer I A Badi, Sana D Jalal.   

Abstract

While previous studies from Iraq have focused on β-thalassemia (β-thal) mutations in the northern part of the country, inhabited mainly by Kurds, no study of significance has looked at these mutations in central or southern Iraq, which is inhabited by the Arab majority. For the latter purpose this study was initiated and 103 β-thal carriers from Baghdad at the center of the country were investigated using multiplex polymerase chain reaction (PCR) and reverse hybridization followed by sequencing. The results revealed that a total of 17 mutations were implicated, six of which, IVS-I-110 (G>A), IVS-II-1 (G>A), IVS-I-5 (G>C), codons 8/9 (+G), IVS-I-I (G>A) and codon 44 (-C), constituted 78.0% of the mutations characterized. Among the 17 mutations identified, six are reported for the first time from Iraq and include: IVS-I, 25 bp deletion, IVS-II-848 (C>A), -28 (A>C), IVS-I-130 (G>C), IVS-I-128 (T>G) and codons 41/42 (-TTCT). The findings of the current study clearly illustrate the genetic heterogeneity of the population of central Iraq, as demonstrated by the presence of a combination of Mediterranean, Asian Indian, Kurdish, Iranian, Egyptian, Saudi Arabian and Turkish mutations that is reflective of the historical background of this part of the country.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23826747     DOI: 10.3109/03630269.2013.810641

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  7 in total

1.  Molecular Characterization of β-Thalassemia in Nineveh Province Illustrates the Relative Heterogeneity of Mutation Distributions in Northern Iraq.

Authors:  Adil A Eissa; Muna A Kashmoola; Sulav D Atroshi; Nasir A S Al-Allawi
Journal:  Indian J Hematol Blood Transfus       Date:  2014-04-02       Impact factor: 0.900

2.  Sickle Cell Disease in Jordan: The Experience of a Major Referral Center.

Authors:  Raida I Oudat; Heba S Abualruz; Nazih Kh Abu Al-Shiek; Eman A Al-Mashaqba; Rawan A Al-Hiari; Hala A Alsoukhni; Ma'mon A Abu Hammad
Journal:  Med Arch       Date:  2021-02

Review 3.  Genetic epidemiology of hemoglobinopathies among Iraqi Kurds.

Authors:  Nasir Al-Allawi; Sarah Al Allawi; Sana D Jalal
Journal:  J Community Genet       Date:  2020-11-22

4.  β -thalassemia intermedia in Northern Iraq: a single center experience.

Authors:  Nasir A S Al-Allawi; Sana D Jalal; Ameen M Mohammad; Sharaza Q Omer; Raji S D Markous
Journal:  Biomed Res Int       Date:  2014-02-27       Impact factor: 3.411

5.  Molecular Analysis of CYP21A2 Gene Mutations among Iraqi Patients with Congenital Adrenal Hyperplasia.

Authors:  Ruqayah G Y Al-Obaidi; Bassam M S Al-Musawi; Munib Ahmed K Al-Zubaidi; Christian Oberkanins; Stefan Németh; Yusra G Y Al-Obaidi
Journal:  Enzyme Res       Date:  2016-09-29

Review 6.  β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint.

Authors:  Vincenzo De Sanctis; Christos Kattamis; Duran Canatan; Ashraf T Soliman; Heba Elsedfy; Mehran Karimi; Shahina Daar; Yasser Wali; Mohamed Yassin; Nada Soliman; Praveen Sobti; Soad Al Jaouni; Mohamed El Kholy; Bernadette Fiscina; Michael Angastiniotis
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-02-20       Impact factor: 2.576

7.  Two Rare Pathogenic HBB Variants in a Patient with β-Thalassemia Intermedia

Authors:  Veysel Sabri Hançer; Tunç Fışgın; Murat Büyükdoğan
Journal:  Turk J Haematol       Date:  2020-02-19       Impact factor: 1.831

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.